NDC 0002-4112-01 - Zyprexa

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0002-4112
Requested NDC: 0002-4112-01
Package NDCs from labels: 0002-4112-30, 0002-4112-01
Manufacturer: Eli Lilly and Company
Effective date: 2025-11-18
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Zyprexa - Eli Lilly and Company	Eli Lilly and Company	2025-11-18	HUMAN PRESCRIPTION DRUG LABEL
Zyprexa	H.J. Harkins Company, Inc. \| Eli Lilly and Company \| Eli Lilly S.A. - Irish Branch \| Evonik Degussa Corporation \| Eli Lilly and Company (Indianapolis) \| Lilly del Caribe, Inc. (PR01) \| Patheon Italia S.p.A. \| Catalent UK Swindon ZYDIS LTD \| Catalent Pharma Solutions LLC - IL \| Sharp Corporation-Conshohocken	2011-10-25	HUMAN PRESCRIPTION DRUG LABEL
Zyprexa - Dispensing Solutions, Inc.	Dispensing Solutions, Inc.	2011-10-04	HUMAN PRESCRIPTION DRUG LABEL
Zyprexa - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2009-11-30	HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unit	National Council for Prescription Drug Programs	2012-07-24	Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0002-4112-30	Zyprexa	30 in 1 BOTTLE	TABLET	30		67

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0002-4112	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	66	Legacy NDC, 1 package rows	20250110_d5051fbc-846b-4946-82df-341fb1216341.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0002-4112-01	EA - Each	0002-4112	af779e5a-fbbc-4bd3-90e0-d5e69f5e7cee	1	2012-07-24
0002-4112-04	EA - Each	0002-4112	56b11108-1b86-463c-9001-2ac77bf26271	1	2012-07-24
0002-4112-30	EA - Each	0002-4112	b214cae4-710a-4b89-94c5-930801920d26	1	2012-07-24
0002-4112-33	EA - Each	0002-4112	126f1982-9352-4445-b349-04ff9d337112	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Aspartame	INACTIVE INGREDIENT	Z0H242BBR1	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Ferric Oxide Red	INACTIVE INGREDIENT	1K09F3G675	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Gelatin	INACTIVE INGREDIENT	2G86QN327L	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Mannitol	INACTIVE INGREDIENT	3OWL53L36A	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Methylparaben Sodium	INACTIVE INGREDIENT	CR6K9C2NHK	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Polyethylene glycol 4000	INACTIVE INGREDIENT	4R4HFI6D95	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Propylparaben Sodium	INACTIVE INGREDIENT	625NNB0G9N	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Tartaric acid	INACTIVE INGREDIENT	W4888I119H	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Triacetin	INACTIVE INGREDIENT	XHX3C3X673	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
OLANZAPINE	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
OLANZAPINE	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Hydroxypropyl cellulose	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Hydroxypropyl cellulose	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
HYPROMELLOSE	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Triacetin	INACTIVE INGREDIENT	XHX3C3X673	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 24 of 114 · 2,276 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dior Forever Skin Wear Flawless Skin True Foundation SPF 20 3WO Warm Olive	OCTISALATE, TITANIUM DIOXIDE	Parfums Christian Dior	6eec7554-38ed-48d4-916d-ab3660fbf703	2026-01-16	Warnings	Exact identifier unii: 15FIX9V2JP
Dior Forever Skin Wear Flawless Skin True Foundation SPF 20 4,5N Neutral	OCTISALATE, TITANIUM DIOXIDE	Parfums Christian Dior	939e6d5c-3dd7-4b01-af18-697dc4ba2d99	2026-01-16	Warnings	Exact identifier unii: 15FIX9V2JP
Dior Forever Skin Wear Flawless Skin True Foundation SPF 20 4,5W Warm	OCTISALATE, TITANIUM DIOXIDE	Parfums Christian Dior	7149784b-3548-4643-abf6-58fde237bb98	2026-01-16	Warnings	Exact identifier unii: 15FIX9V2JP
Dior Forever Skin Wear Flawless Skin True Foundation SPF 20 4N Neutral	OCTISALATE, TITANIUM DIOXIDE	Parfums Christian Dior	061181d8-5387-4541-a7d7-426cba5997a0	2026-01-16	Warnings	Exact identifier unii: 15FIX9V2JP
Dior Forever Skin Wear Flawless Skin True Foundation SPF 20 4WO Warm Olive	OCTISALATE, TITANIUM DIOXIDE	Parfums Christian Dior	f6ad554a-4795-4149-b066-c53a0989470e	2026-01-16	Warnings	Exact identifier unii: 15FIX9V2JP
Dior Forever Skin Wear Flawless Skin True Foundation SPF 20 4W Warm	OCTISALATE, TITANIUM DIOXIDE	Parfums Christian Dior	58efeaaf-d3c6-44e9-b60f-8f22f5bb1d33	2026-01-16	Warnings	Exact identifier unii: 15FIX9V2JP
Dior Forever Skin Wear Flawless Skin True Foundation SPF 20 4WP Warm Peach	OCTISALATE, TITANIUM DIOXIDE	Parfums Christian Dior	f6b4a90b-5905-4f62-9e35-f2b1dda8dddd	2026-01-16	Warnings	Exact identifier unii: 15FIX9V2JP
BRUSH and GO SPF 50 ALL SKIN TYPES BROAD SPECTRUM	TITANIUM DIOXIDE, OCTINOXATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE, AND OXYBENZONE	Noon Aesthetics M.R. Ltd	0d9f132c-7630-4261-a0f8-fc7a4377731f	2026-01-16	Warnings	Exact identifier unii: 15FIX9V2JP
BRUSH and GO SPF 50 OILY/PROBLEMATIC SKIN BROAD SPECTRUM	TITANIUM DIOXIDE, OCTINOXATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE, AND OXYBENZONE	Noon Aesthetics M.R. Ltd	f292da7d-ffd2-41c3-9a64-619aab19ff18	2026-01-15	Warnings	Exact identifier unii: 15FIX9V2JP
Multivit Sun Protector	TITANIUM DIOXIDE, OCTOCRYLENE, AND AVOBENZONE	Noon Aesthetics M.R. Ltd	abdb560d-29be-41dc-ad23-54ea571acb14	2026-01-15	Warnings	Exact identifier unii: 15FIX9V2JP
NELLY DEVUYST BIOSOLAR COLORLIFT 3 TINTED SUNSCREEN SPF30	ZINC OXIDE	LABORATOIRES DRUIDE INC	19af4441-31b2-72db-e063-6394a90a813c	2026-01-14	Warnings	Exact identifier unii: 15FIX9V2JP
SCENTUAL AROMA BEAUTY SUN VEIL SPF30	TITANIUM DIOXIDE, ZINC OXIDE	LABORATOIRES DRUIDE INC	0799ac38-9a41-6579-e063-6394a90ac4b6	2026-01-14	Warnings	Exact identifier unii: 15FIX9V2JP
Bluevado Sunfix	ZINC OXIDE, TITANIUM DIOXIDE	Magic Blue, LLC	2e5315bf-39f4-401c-8207-18ef6a97e024	2026-01-13	Warnings	Exact identifier unii: 15FIX9V2JP
Intellishade TruPhysical SPF 45	TITANIUM DIOXIDE, ZINC OXIDE	Revision, LLC	e20f5dc9-e863-b090-e053-2a95a90a5044	2026-01-13	Warnings	Exact identifier unii: 15FIX9V2JP
Intellishade TruPhysical Clear SPF 50	TITANIUM DIOXIDE, ZINC OXIDE	Revision, LLC	1305fa94-47d5-7a42-e063-6394a90a0aba	2026-01-13	Warnings	Exact identifier unii: 15FIX9V2JP
Intellishade Matte SPF 45	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE	Revision, LLC	e213ae87-4db2-3070-e053-2995a90a083b	2026-01-13	Warnings	Exact identifier unii: 15FIX9V2JP
Blue Lizard Sensitive SPF 50 Sunscreen	TITANIUM DIOXIDE AND ZINC OXIDE	Crown Laboratories	9d20b230-2cce-4d90-e053-2995a90a4c03	2026-01-12	Warnings	Exact identifier unii: 15FIX9V2JP
Blue Lizard Sheer SPF 50 Sunscreen	TITANIUM DIOXIDE, ZINC OXIDE	Crown Laboratories	c20fce25-8120-fe5d-e053-2a95a90a53a0	2026-01-12	Warnings	Exact identifier unii: 15FIX9V2JP
Blue Lizard Sheer Face SPF 50 Sunscreen	TITANIUM DIOXIDE AND ZINC OXIDE	Crown Laboratories	baed8202-21fd-3a43-e053-2a95a90ada32	2026-01-12	Warnings	Exact identifier unii: 15FIX9V2JP
Blue Lizard Sensitive Face Sunscreen	TITANIUM DIOXIDE, ZINC OXIDE	Crown Laboratories	88dbd396-8955-271e-e053-2995a90a0a7a	2026-01-12	Warnings	Exact identifier unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.